Elevance Health, Inc. $ELV Stock Position Lessened by Newport Trust Company LLC

Newport Trust Company LLC decreased its holdings in Elevance Health, Inc. (NYSE:ELV) by 1.9% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,005,020 shares of the company’s stock after selling 18,997 shares during the quarter. Elevance Health accounts for approximately 0.8% of Newport Trust Company LLC’s holdings, making the stock its 22nd largest position. Newport Trust Company LLC’s holdings in Elevance Health were worth $352,310,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of ELV. Physician Wealth Advisors Inc. boosted its stake in Elevance Health by 331.6% during the third quarter. Physician Wealth Advisors Inc. now owns 82 shares of the company’s stock valued at $26,000 after buying an additional 63 shares in the last quarter. Activest Wealth Management boosted its stake in Elevance Health by 66.7% during the third quarter. Activest Wealth Management now owns 85 shares of the company’s stock valued at $27,000 after buying an additional 34 shares in the last quarter. Rossby Financial LCC boosted its stake in Elevance Health by 110.0% during the third quarter. Rossby Financial LCC now owns 84 shares of the company’s stock valued at $28,000 after buying an additional 44 shares in the last quarter. ORG Partners LLC boosted its stake in Elevance Health by 120.4% during the fourth quarter. ORG Partners LLC now owns 108 shares of the company’s stock valued at $38,000 after buying an additional 59 shares in the last quarter. Finally, Loring Wolcott & Coolidge Fiduciary Advisors LLP MA bought a new position in Elevance Health during the fourth quarter valued at about $38,000. Institutional investors own 89.24% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on ELV. The Goldman Sachs Group raised their target price on Elevance Health from $350.00 to $370.00 and gave the company a “neutral” rating in a research note on Friday, April 24th. Leerink Partners set a $364.00 target price on Elevance Health in a research note on Thursday, April 23rd. Mizuho raised their target price on Elevance Health from $385.00 to $435.00 and gave the company an “outperform” rating in a research note on Wednesday. Evercore reaffirmed a “hold” rating on shares of Elevance Health in a research note on Tuesday. Finally, Citigroup raised Elevance Health to a “buy” rating in a research note on Wednesday, April 29th. Fourteen research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat, Elevance Health has a consensus rating of “Moderate Buy” and an average target price of $396.16.

Elevance Health Trading Down 1.8%

Shares of NYSE ELV opened at $389.17 on Friday. Elevance Health, Inc. has a 12 month low of $273.71 and a 12 month high of $408.00. The company has a market cap of $84.51 billion, a price-to-earnings ratio of 16.55, a P/E/G ratio of 2.24 and a beta of 0.66. The company has a quick ratio of 1.48, a current ratio of 1.48 and a debt-to-equity ratio of 0.70. The business has a fifty day simple moving average of $331.71 and a 200-day simple moving average of $335.84.

Elevance Health (NYSE:ELV) last announced its earnings results on Wednesday, April 22nd. The company reported $12.58 EPS for the quarter, beating the consensus estimate of $10.74 by $1.84. Elevance Health had a return on equity of 15.58% and a net margin of 2.62%.The business had revenue of $49.49 billion during the quarter, compared to the consensus estimate of $48.21 billion. During the same period in the prior year, the business posted $11.97 earnings per share. Elevance Health’s revenue was up 1.5% compared to the same quarter last year. Elevance Health has set its FY 2026 guidance at 19.850- EPS. Sell-side analysts predict that Elevance Health, Inc. will post 26.94 EPS for the current year.

Elevance Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Wednesday, June 10th will be issued a dividend of $1.72 per share. This represents a $6.88 annualized dividend and a dividend yield of 1.8%. The ex-dividend date of this dividend is Wednesday, June 10th. Elevance Health’s dividend payout ratio is currently 29.26%.

Elevance Health Company Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.